None
Quote | Oragenics Inc. (NYSE:OGEN)
Last: | $1.03 |
---|---|
Change Percent: | -6.86% |
Open: | $1.09 |
Close: | $1.03 |
High: | $1.09 |
Low: | $1.02 |
Volume: | 80,446 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Oragenics Inc. (NYSE:OGEN)
2024-06-28 13:53:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Oragenics (NYSEMKT: OGEN ) just reported results for the fourth quarter of 2023. Oragenics reported earnings per share of -$5.48. The company did not report any revenu...
2024-06-27 08:59:56 ET More on Oragenics Oragenics prices public offering of common stock Oragenics climbs 9% amid Phase 2 study, business updates Financial information for Oragenics Read the full article on Seeking Alpha For further details see: ...
Message Board Posts | Oragenics Inc. (NYSE:OGEN)
Subject | By | Source | When |
---|---|---|---|
Maybe not. :) | retired early | investorshub | 03/01/2023 6:46:26 PM |
Don't madder they will short it down to nothing | Nathan123456 | investorshub | 12/22/2022 10:32:36 PM |
Surfs up. ::) | retired early | investorshub | 12/22/2022 2:35:47 PM |
Chart setup perfectly here -> time is koming | BEIJING BILL | investorshub | 08/17/2022 4:51:49 PM |
Hey whatever it takes to see it rise | retired early | investorshub | 05/27/2022 5:06:22 PM |
News, Short Squeeze, Breakout and More Instantly...
SARASOTA, Fla., June 27, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced it has completed a prototype of its automated intranasal device for use in concu...
SARASOTA, Fla., June 26, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced the closing of its public offering of 1,100,000 shares of its common stock ...